NCT07379125 2026-01-30
Therapeutic RSK1 Targeting in Myelofibrosis
Washington University School of Medicine
Phase 1 Not yet recruiting
Clinical Trials
4 trialsNCT03895112 2023-02-10
MPN-RC 118 AVID200 in Myelofibrosis
Icahn School of Medicine at Mount Sinai
Phase 1 Completed
NCT02730884 2020-08-07
Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02421354 2019-05-15
Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis
M.D. Anderson Cancer Center
Phase 2 Terminated